Functional roles of glycogene and N-glycan in multidrug resistance of human breast cancer cells

IUBMB Life

Volumn 65, Issue 5, 2013, Pages 409-422

  Ma, Hongye ^a   Miao, Xiaoyan ^a   Ma, Qiuhong ^a   Zheng, Wenzhi ^b   Zhou, Huimin ^a   Jia, Li ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

glycogene; human breast cancer cell line; multidrug resistance; N glycans

Indexed keywords

DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; GLYCAN; GLYCOGEN; LECTIN; TUNICAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL SURFACE; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGLYCOSYLATION; DOWN REGULATION; FUCOSYLATION; GENE EXPRESSION PROFILING; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA INTERFERENCE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MCF-7 CELLS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NERVE TISSUE PROTEINS; POLYSACCHARIDES;

EID: 84876944143     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1133     Document Type: Article

References (38)

1. Hakomori, S., (1996) Tumor malignancy defined by aberrant glycosylation and sphingoglycolipid metabolism. Cancer Res. 56, 5309-5318. (Pubitemid 27011703)
2. Dwek, R. A., (1996) Glycobiology: toward understanding the function of sugars. Chem. Rev. 96, 683-720. (Pubitemid 126649163)
3. Ihara, S., Miyoshi, E., Ko, J. H., Murata, K., Nakahara, S., et al. (2002) Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J. Biol. Chem. 277, 16960-16967. (Pubitemid 34967724)
4. Kudo, T., Nakagawa, H., Takahashi, M., Hamaguchi, J., Kamiyama, N., Honke, K., Dickson, R. B., Lin, C. Y., and, Taniguchi, N., (2007) N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma. Mol. Cancer 6, 32-40.
5. Sharom, F. J., (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9, 105-127. (Pubitemid 351560534)
6. Kvackajova-Kisucka, J., Barancik, M., and, Breier, A., (2001) Drug transporters and their role in multidrug resistance of neoplastic cells. Gen. Physio. Biophys. 20, 215-237. (Pubitemid 33040351)
7. Bosch, T. M., (2008) Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Methods Mol. Biol. 448, 63-76.
8. Inoue, S., Salah-Eldin, A. E., and, Omoteyama, K., (2001) Apoptosis and anticancer drug resistance. Hum Cell. 14, 211-221.
9. Haltiwanger, R. S., and, Lowe, J. B., (2004) Role of glycosylation in development. Annu. Rev. Biochem. 73, 491-537. (Pubitemid 39050378)
10. Fiala, R., Sulová, Z., El-Saggan, A. H., Uhrík, B., Liptaj, T., Dovinová, I., Hanusovská, E., Drobná, Z., Barancík, M., and, Breier, A., (2003) P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents. Biochim. Biophys. Acta 1639, 213-224. (Pubitemid 37424036)
11. Dall'Olio, F., Malagolini, N., Guerrini, S., and, Serafini-Cessi, F., (1993) Resistance to methotrexate is associated with selective changes of α 2,6- and α 2,3-sialyltransferase activities toward N-acetyllactosaminic sequences in human colon cancer cell line HT-29. Biochem. Biophys. Res. Commun. 196, 714-720. (Pubitemid 23337666)
12. Nakahara, S., Miyoshi, E., Noda, K., Ihara, S., Gu, J., Honke, K., Inohara, H., Kubo, T., and, Taniguchi, N., (2003) Involvement of oligosaccharide changes in α 5β 1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line. Mol. Cancer Ther. 2, 1207-1214.
13. Kudo, T., Nakagawa, H., Takahashi, M., Hamaguchi, J., Kamiyama, N., Yokoo, H., Nakanishi, K., Nakagawa, T., Kamiyama, T., Deguchi, K., Nishimura, S., and, Todo, S., (2007) N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma. Mol. Cancer 6, 32-39.
14. Lattová, E., Tomanek, B., Bartusik, D., and, Perreault, H., (2010) N-glycomic changes in human breast arcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex. J. Proteome Res. 9, 1533-1540.
15. Zhang, Z., Zhao, Y., Jiang, L., Miao, X., Zhou, H., and, Jia, L., (2012) Glycomic alterations are associated with multidrug resistance in human leukemia. Int. J. Biochem. Cell. Biol. 44, 1244-1253.
16. Costello, C. E., Contado-Miller, J. M., and, Cipollo, J. F., (2007) A glycomics platform for the analysis of permethylated oligosaccharide alditols. J. Am. Soc. Mass Spectrom. 18, 1799-1812. (Pubitemid 47419346)
17. Viseux, N., Costello, C. E., and, Domon, B., (1999) Post-source decay mass spectrometry: optimized calibration procedure and structural characterization of permethylated oligosaccharides. J. Mass Spectrom. 34, 364-376. (Pubitemid 29182488)
18. Sieczkowski, E., Lehner, C., Ambros, P. F., and, Hohenegger, M., (2010) Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells. Int. J. Cancer 126, 2025-2035.
19. Venable, A., Mitalipova, M., Lyons, I., Jones, K., Shin, S., Pierce, M., and, Stice, S., (2005) Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces. BMC Dev. Biol. 21, 5-15.
20. Elloway, E. A., Armstrong, R. A., Bird, R. A., Kelly, S. L., and, Smith, S. N., (2004) Analysis of Acanthamoeba polyphaga surface carbohydrate exposure by FITC-lectin binding and fluorescence evaluation. J. Appl. Microbiol. 97, 1319-1325. (Pubitemid 39573956)
21. Dell, A., and, Morris, H. R., (2001) Glycoprotein structure determination by mass spectrometry. Science 291, 2351-2356. (Pubitemid 32231789)
22. Harvey, D. J., (2005) Proteomic analysis of glycosylation: structural determination of N-and O-linked glycans by mass spectrometry. Expert Rev. Proteomics 2, 87-101. (Pubitemid 40292582)
23. Zaia, J., (2004) Mass spectrometry of oligosaccharides. Mass Spectrom. Rev. 3, 161-227.
24. Hu, J., Lin, M., Liu, T., Li, J., Chen, B., and, Chen, T., (2011) DIGE-based proteomic analysis identifies nucleophosmin/B23 and nucleolin C23 as over-expressed proteins in relapsed/refractory acute leukemia. Leuk. Res. 35, 1087-1092.
25. Michele, M. D., Marcone, S., Cicchillitti, L., Corte, A. D., Ferlini, C., Scambia, G., Donati, M. B., and, Rotilio, D., (2010) Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: towards the identification of putative biomarkers. Proteomics 73, 879-898.
26. Dwek, R. A., (1996) Glycobiology: toward understanding the function of sugars. Chem. Rev. 96, 683-720. (Pubitemid 126649163)
27. Varki, A., (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97-130. (Pubitemid 23132602)
28. Schinkel, A. H., Kemp, S., Dolle′, M., Rudenko, G., and, Wagenaar, E., (1993) N-Glycosylation and deletion mutants of the human MDR1 Pglycoprotein. J. Biol. Chem. 268, 7474-7481. (Pubitemid 23105645)
29. Wang, Y., Loo, T. W., Bartlett, M. C., and, Clarke, D. M., (2007) Modulating the folding of Pglycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones. Mol. Pharmacol. 71, 751-758. (Pubitemid 46294086)
30. Bentley, J., Quinn, D. M., Pitman, R. S., Warr, J. R., and, Kellett, G. L., (1997) The human KB multidrugresistant cell line KB-Cl is hypersensitive to inhibitors of glycosylation. Cancer Lett. 115, 221-227. (Pubitemid 27196609)
31. Loo, T. W., and, Clarke, D. M., (1999) The human multidrug resistance P-glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy. FASEB J. 13, 1724-1730.
32. Tang, W., Chang, S. B., and, Hemler, M. E., (2004) Links between CD147 function, glycosylation, and Caveolin-1. Mol. Biol. Cell 15, 4043-4050. (Pubitemid 39122010)
33. Yang, J. M., Xu, Z., Wu, H., Zhu, H., Wu, X., and, Hait, W. N., (2003) Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol. Cancer Res. 1, 420-427. (Pubitemid 36459252)
34. Zou, W., Zhu, H., and, Wu, X., (2006) Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett. 248, 211-218.
35. Jia, L., Xu, H., Zhao, Y., Jiang, L., Yu, J., and, Zhang, J., (2008) Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma. Cancer Invest. 26, 977-983.
36. Taniguchi, N., Miyoshi, E., Ko, J. H., Ikeda, Y., and, Ihara, Y., (1999) Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim. Biophys. Acta 1455, 287-300. (Pubitemid 29435995)
37. Granovsky, M., Fata, J., Pawling, J., Muller, W. J., Khokha, R., and, Dennis, J. W., (2000) Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6, 306-312. (Pubitemid 30148623)
38. Guo, R., Cheng, L., Zhao, Y., Zhang, J., Liu, C., Zhou, H., and, Jia, L., (2012) Glycogenes mediate the invasive properties and chemosensitivity of human hepatocarcinoma cells. Int. J. Biochem. Cell. Biol. 45, 347-358.